Velcade and Olmetec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Velcade (bortezomib) and Olmetec (olmesartan medoxomil). Common drug interactions include asthma among females and hyperkalaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Velcade and Olmetec. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.

What is Olmetec?

Olmetec has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 7,904 Olmetec users. Check the latest studies of Olmetec.

On Jul, 13, 2026

30 people who take Velcade and Olmetec together, and have interactions are studied.

What are the common drug interactions of Velcade and Olmetec, by gender? *:

female:

Asthma
Infection
Diarrhoea
Cytomegalovirus infection
Hypokalaemia (low potassium)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Oedema (fluid collection in tissue)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Pulmonary artery thrombosis (blockage of the main artery of the lung)
Rash

male:

Hyperkalaemia (damage to or disease of the kidney)
Back pain
Platelet count decreased
Pyrexia (fever)
Diarrhoea
Hyperglycaemia (high blood sugar)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypokalaemia (low potassium)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Velcade and Olmetec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Chills (felling of cold)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Diarrhoea
Flushing (the warm, red condition of human skin)
Hypercapnia (too much smoke)
Hyperventilation
Malaise (a feeling of general discomfort or uneasiness)
Oxygen saturation decreased
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

Hyperkalaemia (damage to or disease of the kidney)
Asthma
Rash generalised (rash on most of body parts)
Diarrhoea
Hypokalaemia (low potassium)
Pyrexia (fever)
Rash
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Anaemia (lack of blood)

What are the existing conditions these people have? *

Oedema (fluid collection in tissue): 6 people, 20.00%
Weight Increased: 4 people, 13.33%
Rashes (redness): 4 people, 13.33%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 4 people, 13.33%
Pain: 4 people, 13.33%
Adverse Event: 4 people, 13.33%
Insomnia (sleeplessness): 3 people, 10.00%
Constipation: 3 people, 10.00%
Anal Fistula: 3 people, 10.00%
Neuropathy Peripheral (surface nerve damage): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Velcade and Olmetec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously